Breakthrough in the fight against ovarian cancer. Blood test will detect precancerous changes

Ovarian cancer, known as the "silent killer," often goes undetected until advanced stages. Researchers have identified a molecule called Tu-Stroma, which may indicate early pre-cancerous changes. A blood test measuring Tu-Stroma levels has shown promising results, effectively detecting both advanced cancer and STIC changes, outperforming the common CA125 marker. This discovery is particularly significant for women with BRCA mutations, as it could guide preventive surgeries based on actual risk rather than assumptions. However, further research is needed before the test can be used in routine diagnostics.